null

Pinatuzumab Biosimilar (Anti-CD22) Antibody (HDBS0029)

SKU:
HDBS0029
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Protein:
CD22
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-CD22 pinatuzumab biosimilar mAb HDBS0029
  • Anti-CD22 pinatuzumab biosimilar mAb HDBS0029
  • Anti-CD22 pinatuzumab biosimilar mAb HDBS0029
€399

Description

system_update_altDatasheet

Pinatuzumab (Anti-CD22) Biosimilar Antibody (HDBS0029)

The Anti-CD22 Pinatuzumab Biosimilar MAb (HDBS0029) offered by Assay Genie is a cutting-edge monoclonal antibody designed for research purposes. This biosimilar MAb specifically targets CD22, a B-cell surface antigen that is highly expressed in B-cell malignancies. This antibody is produced using state-of-the-art biotechnology methods, ensuring high specificity and sensitivity in detecting CD22 in various samples. It is validated for use in techniques such as flow cytometry, immunohistochemistry, and immunoprecipitation, making it an invaluable tool for researchers studying B-cell related diseases like leukemia and lymphoma.

The Anti-CD22 Pinatuzumab Biosimilar MAb (HDBS0029) holds great promise in advancing our understanding of B-cell biology and developing targeted therapies for B-cell derived cancers. Its high affinity for CD22 and reliable performance in experimental settings make it a valuable asset for researchers seeking to uncover new insights into the mechanisms underlying these diseases.

Product Name:Pinatuzumab (Anti-CD22) Biosimilar Antibody
Size:100 ug
Product SKU:HDBS0029
Target:CD22
Host Species:Humanized
Reactivity:Human
Recommended Dilution:ELISA 1:5000-10000
Antibody Type:Monoclonal
Buffer:Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000
Description:Anti-CD22 (pinatuzumab biosimilar) mAb
Buffer:Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:Powder
ApplicationsELISA
Antibody Isotype:IgG1
Guarantee:12 months from date of dispatch
Background:Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Synonyms:CD22, SIGLEC2, BL-CAM, SIGLEC-2, Siglec2, SIGLEC2FLJ22814
Uniprot:P20273

Related Products